These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17506920)

  • 1. Estimating the impact of vaccination using age-time-dependent incidence rates of hepatitis B.
    Hens N; Aerts M; Shkedy Z; Kung'u Kimani P; Kojouhorova M; van Damme P; Beutels P
    Epidemiol Infect; 2008 Mar; 136(3):341-51. PubMed ID: 17506920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of immigration and vaccination in reducing the incidence of hepatitis B in Catalonia (Spain).
    Oviedo M; Muñoz MP; Carmona G; Borrás E; Batalla J; Soldevila N; Domínguez A
    BMC Public Health; 2012 Aug; 12(1):614. PubMed ID: 22867276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hepatitis B vaccination on acute hepatitis B epidemiology in European Union/European Economic Area countries, 2006 to 2014.
    Miglietta A; Quinten C; Lopalco PL; Duffell E
    Euro Surveill; 2018 Feb; 23(6):. PubMed ID: 29439751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant immunization program.
    Gîlca V; Duval B; Boulianne N; Dion R; De Serres G
    Pediatr Infect Dis J; 2006 Apr; 25(4):372-4. PubMed ID: 16567995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus infection: epidemiology and vaccination.
    Shepard CW; Simard EP; Finelli L; Fiore AE; Bell BP
    Epidemiol Rev; 2006; 28():112-25. PubMed ID: 16754644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunisation after hepatitis B polyvalent vaccination among children in South Kivu Province, Democratic Republic of the Congo.
    Shindano TA; Mbusa RK; Kabamba BM; Fiasse R; Horsmans Y
    S Afr Med J; 2019 Apr; 109(5):319-322. PubMed ID: 31131798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014.
    Zhou Y; He H; Deng X; Yan R; Tang X; Xie S; Yao J
    Vaccine; 2017 Aug; 35(34):4355-4361. PubMed ID: 28687404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease.
    Nelson NP; Easterbrook PJ; McMahon BJ
    Clin Liver Dis; 2016 Nov; 20(4):607-628. PubMed ID: 27742003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccines.
    Wkly Epidemiol Rec; 2009 Oct; 84(40):405-19. PubMed ID: 19817017
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiology of hepatitis B and hepatitis B virus infection in United States children.
    Shepard CW; Finelli L; Fiore AE; Bell BP
    Pediatr Infect Dis J; 2005 Sep; 24(9):755-60. PubMed ID: 16148839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The next step in controlling HBV in China.
    Xu Y; Liu H; Wang Y; Hao R; Li Z; Song H
    BMJ; 2013 Jul; 347():f4503. PubMed ID: 23861426
    [No Abstract]   [Full Text] [Related]  

  • 13. Denmark decides not to introduce hepatitis B into the childhood vaccination programme.
    Cowan SA
    Euro Surveill; 2005 Nov; 10(11):E051103.3. PubMed ID: 16794274
    [No Abstract]   [Full Text] [Related]  

  • 14. Universal childhood hepatitis B vaccination: infants vs. preadolescents, the Canadian perspective.
    Scheifele D
    Pediatr Infect Dis J; 1998 Jul; 17(7 Suppl):S35-7. PubMed ID: 9688098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of universal newborn hepatitis B vaccination in China.
    Lu SQ; McGhee SM; Xie X; Cheng J; Fielding R
    Vaccine; 2013 Apr; 31(14):1864-9. PubMed ID: 23384752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-dose hepatitis B vaccination schedule in travelers presenting for late consultation.
    Wong J; Payne M; Hollenberg S
    J Travel Med; 2014; 21(4):260-5. PubMed ID: 24796543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of viral hepatitis B epidemiological process in Plovdiv region.
    Kevorkyan-Sariyan AK
    Folia Med (Plovdiv); 2013; 55(2):97-8. PubMed ID: 24191410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 19. An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy.
    La Torre G; Nicolotti N; de Waure C; Chiaradia G; Specchia ML; Mannocci A; Ricciardi W
    Virol J; 2008 Jul; 5():84. PubMed ID: 18652653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.